Murphy & Mullick Capital Management
CVS icon

Murphy & Mullick Capital Management’s CVS Health CVS Stock Holding History

Murphy & Mullick Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$45.5K Buy
531
+6
+1% +$587 0.03% 306
2026
Q2 		$54.3K Sell
525
-14
-3% -$1.25K 0.03% 287
2026
Q1 		$38.7K Buy
539
+26
+5% +$2K 0.03% 317
2025
Q4 		$40.7K Sell
513
-86
-14% -$6.78K 0.03% 322
2025
Q3 		$45.2K Sell
599
-631
-51% -$43.2K 0.03% 291
2025
Q2 		$76.7K Sell
1,230
-156
-11% -$10.2K 0.06% 215
2025
Q1 		$93.9K Sell
1,386
-10
-0.7% -$598 0.09% 182
2024
Q4 		$62.7K Buy
+1,396
New +$78.3K 0.06% 230

Other funds holding CVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Murphy & Mullick Capital Management's CVS Position: Q3 2026 in Review

Murphy & Mullick Capital Management increased its CVS Health (CVS) stake by 1.1% in Q3 2026, buying an estimated $587 and bringing the position to 531 shares worth $45.5K. The position accounts for 0.03% of the portfolio, ranked #306.

Murphy & Mullick Capital Management first reported a position in CVS in Q4 2024 and has held it in 8 quarters since. The position peaked at $93.9K in Q1 2025. 1,215 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Murphy & Mullick Capital Management held 531 shares of CVS Health worth $45.5K as of Q3 2026.
  • Murphy & Mullick Capital Management bought 6 CVS Health shares in Q3 2026, an estimated $587.
  • CVS Health made up 0.03% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #306 holding.
  • Murphy & Mullick Capital Management first reported a position in CVS Health in Q4 2024 and has held it in 8 quarters since.
  • Murphy & Mullick Capital Management's CVS Health position peaked at $93.9K in Q1 2025.
  • 1,215 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.